Publications
Chosen filters:
Chosen filters:
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C. KU Leuven
BACKGROUND AND RATIONALE: The REPLACE study (NCT01571583) investigated telaprevir-based triple therapy in patients who have recurrent genotype 1 hepatitis C virus (HCV) infection following liver transplantation and are on a stable immunosuppressant regimen of tacrolimus or cyclosporin A. Patients received telaprevir 750 mg 8-hourly with pegylated interferon 180 μg weekly and ribavirin 600 mg daily, followed by a further 36 weeks of pegylated ...